Validation of a scoring system to evaluate the risk of rapid growth of intracranial meningiomas in neurofibromatosis type 2 patients.

CONCLUSIONS: The AIMSS score is valid in the authors' cohort of NF2-related meningiomas. It adequately predicted risk of rapid meningioma growth and could aid in decision-making in NF2 patients.
PMID: 32442973 [PubMed - as supplied by publisher]

Source: Journal of Neurosurgery - May 21, 2020 Category: Neurosurgery Authors: Abi Jaoude S, Peyre M, Degos V, Goutagny S, Parfait B, Kalamarides M Tags: J Neurosurg Source Type: research